Brad Meikle

DFJ targets nanotechnology

VCs back GreenPeak

Gimv leads €13m funding

Foresight continues solar expansion

Spanish director recruited

Enterprise supports stem cells

Polish company receives expansion capital

Permira replaces Paris head

Philippe Robert retires

Capstone appoints

Placement agent expands European team

Close Bros reshuffles senior management

Aulsebrook and Madden receive promotions

Fondinvest hires partner

PE veteran joins French firm

New model pharma

With investor confidence in the biotech sector taking a massive hit in the wake of the recession, VCs are pushing a new approach to backing early-stage companies in a bid to win back support

‘This is venture capital’s last chance to prove itself’

The industry is at a crossroads and all sides need to pull together to ensure the future of the industry, says Uli Grabenwarter, head of equity fund investments at the European Investment Fund